Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smooth muscle phosphatases: structure, regulation, and function

M D Pato1, A G Tulloch, M P Walsh

  • 1Department of Biochemistry, University of Saskatchewan, Saskatoon, Canada.

Canadian Journal of Physiology and Pharmacology
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AMKL chimeric transcription factors are potent inducers of leukemia.

Leukemia·2017
Same author

Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.

Oncogene·2013
Same author

Integrin-linked kinase: not so 'pseudo' after all.

Oncogene·2011
Same author

Augmented Hopfield network for mixed-integer programming.

IEEE transactions on neural networks·2008
Same author

Quantum dot superlattice thermoelectric materials and devices.

Science (New York, N.Y.)·2002
Same author

Molecular composition of 4-aminopyridine-sensitive voltage-gated K(+) channels of vascular smooth muscle.

Circulation research·2001
Same journal

Impact of inhalational anesthetics on neurodegeneration in Alzheimer's disease: current evidence and potential implications.

Canadian journal of physiology and pharmacology·2026
Same journal

Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

Canadian journal of physiology and pharmacology·2026
Same journal

Exploring the causal relationship between inflammatory cytokines and diabetic foot ulcer: A bidirectional Mendelian randomization and clinical validation study.

Canadian journal of physiology and pharmacology·2026
Same journal

TRPV1, Endocannabinoid, and Opioid Systems in Analgesia: Molecular Mechanisms and Drug Development Strategies.

Canadian journal of physiology and pharmacology·2026
Same journal

Association of stromal cell derived factor 1α and interferon-γ induced protein 10 with Fontan pathophysiology.

Canadian journal of physiology and pharmacology·2026
Same journal

Incretins for Type 2 Diabetes.

Canadian journal of physiology and pharmacology·2026
See all related articles

Researchers identified novel smooth muscle phosphatases (SMPs) that regulate muscle contraction. SMP-III and SMP-IV are key to smooth muscle relaxation, while SMP-I modulates regulatory protein activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Muscle Physiology

Background:

  • Smooth muscle contraction is primarily regulated by myosin phosphorylation via myosin light chain kinase.
  • Secondary regulatory mechanisms involve phosphorylation/dephosphorylation of myosin light chain kinase and thin-filament proteins like caldesmon and calponin.

Purpose of the Study:

  • To identify and characterize protein phosphatases involved in smooth muscle contraction and relaxation.
  • To elucidate the specific roles of purified smooth muscle phosphatases (SMPs) in regulating myosin and thin-filament proteins.

Main Methods:

  • Purification of cytosolic smooth muscle phosphatases (SMP-I, -II, -III, -IV) from turkey gizzard.
  • Assays to determine phosphatase activity towards myosin light chains, myosin, heavy meromyosin, caldesmon, and calponin.

Related Experiment Videos

  • Characterization of SMP properties, including comparison to known phosphatase types (e.g., type 1 and type 2A).

    • Main Results:

    • SMP-I, -II, -III, and -IV rapidly dephosphorylate myosin light chains.
    • SMP-III and SMP-IV show activity towards myosin and heavy meromyosin, suggesting a direct role in smooth muscle relaxation.
    • SMP-III and SMP-IV exhibit properties of type 1 protein phosphatases.
    • SMP-I, identified as a type 2A protein phosphatase, dephosphorylates calponin and caldesmon, and also acts on myosin light chain kinase.

    Conclusions:

    • SMP-III and SMP-IV are likely directly involved in smooth muscle relaxation by dephosphorylating myosin.
    • SMP-I plays a regulatory role in smooth muscle contractility by modulating the activity of caldesmon, calponin, and potentially myosin light chain kinase.